Shen YC, Liu TH, Nicholas A, Soyama A, et al. Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab. J Clin Oncol 2024 Aug 28:JCO2400645. doi: 10.1200/JCO.24.00645.
PMID: 39197119